Summary of 2 drug monitoring studies studies on the efficiency and safety of Hypericum in the treatment of depression.

Authors year	No	substance	dose	Hamilton start end	DS - scale start end	Resp rate	Side eff.	weeks	drop outs	Inclusion criteria
Albrecht 1994	1060	Jarsin	0,37mg x 3	18.4 5.4	21.1 7.3	93%	2 %	4	5,9%	ICD 10 F32.1
Woelk 1993	3250	Jarsin 300	0,9 mg x 3	-	23.2 11.8	82%	2,4%	4	1.5%	Mild, moderate and severe depr.

Click Here for Index of Charts & Tables